Roivant Sciences Ltd (NASDAQ:ROIV) does about 6.43M shares in volume on a normal day but saw 11362541 shares change hands in Friday trading. The company now has a market cap of 7.81B USD. Its current market price is $10.57, marking no change compared to the previous close of $10.57. The 52 week high reached by this stock is $13.24 whilst the lowest price level in 52 weeks is $8.24.
Roivant Sciences Ltd (ROIV) has a 20-day trading average at $10.69 and the current price is -20.17% off the 52-week high compared with 28.20% distance from its 52-week low. The 50-day simple moving average of the closing price is $10.92 and its 200-day simple moving average is $10.54. If we look at the stock’s price movements over the week, volatility stands at 2.62%, which increases to 3.04% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 43.67 to suggest the stock is neutral.
The consensus objective for the share price is $16.68, suggesting that the stock has a potential upside of 36.63% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on February 15, 2024 when Wolfe Research initiated the stock to “Outperform” and issued a price target of $17. Deutsche Bank initiated its price target at $14.
Roivant Sciences Ltd (ROIV) stock is down -1.12% over the week and -1.49% over the past month. Its price is -5.88% year-to-date and 4.97% over the past year.
To reach the target analysts have set, the stock logically needs to grow 36.63 percent from here.
The company has a return on investment of 67.46% and return on equity of 122.05%. The price to earnings ratio (P/E ratio) amounts to 2.09. The beta has a value of 1.24. Price to book ratio is 1.43 and price to sales ratio is 62.57.
